Skip to main content
SpringerLink
Log in

Pediatric Heart Transplantation

  • Chapter
  • First Online:
Cardiac Surgery

  • 206 Accesses

Abstract

Pediatric heart transplantation dates back to December 1967, with Kantrowitz’s unsuccessful attempt at infant heart transplantation. Sixteen years later, Bailey ushered in the era of clinical infant heart transplantation after a failed xenotransplant attempt. Today, more than 700 pediatric heart transplants are performed annually, with average survival exceeding 90% at 1 year and, among infants, a median survival of more than 20 years. Major causes of death include graft failure, allograft vasculopathy, rejection, infection, and malignancy. With current preservation techniques, the incidence of early graft failure has been reduced to about 2%. About 40% of patients experience one or more rejection episodes in the first year. Antibody mediated rejection is much less common but when associated with hemodynamic compromise 50% of patients die within 5 years. Infection incidence is time-related, with bacterial infections most prevalent in the first 2 months. Post-transplant lymphoproliferative disease is caused by Epstein-Barr virus in over 80% of cases, and the greatest risk is between 6 and 12 months. Allograft vasculopathy, a manifestation of chronic rejection, affects 15% of patients by 5 years and 30% by 10 years. Allograft vasculopathy is the most common indication for retransplantation with expected graft survival only slightly worse than with the original graft.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Kantrowitz A. America’s first human heart transplantation: the concept, the planning, and the furor. ASAIO J. 1998;44:244–52.

    Article  CAS  Google Scholar 

  2. Rossano JW, Cherikh WS, Chambers DC, Goldfarb S, Khush K, Kucheryavaya AY, Levvey BJ, Lund LH, Meiser B, Yusen RD, Stehlik J, International Society for Heart and Lung Transplantation. The Registry of the International Society for Heart and Lung Transplantation: Twentieth Pediatric Heart Transplantation Report-2017; Focus theme: Allograft ischemic time. J Heart Lung Transplant. 2017;36:1060–9.

    Article  Google Scholar 

  3. Lipshultz SE, Colan SD, Gelber RD, Perez-Atayde AR, Sallan SE, Sanders SP. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med. 1991;324:808–15.

    Article  CAS  Google Scholar 

  4. Maron BJ. Hypertrophic cardiomyopathy: interrelation of clinical manifestations, pathophysiology, and therapy. N Engl J Med. 1987;316:852.

    Article  Google Scholar 

  5. Fricker FJ, Addonizio L, Bernstein D, Boucek M, Boucek R, Canter C, Chinnock R, Chin C, Kichuk M, Lamour J, Pietra B. Heart transplantation in children: indications. Pediatr Transplant. 1999;3:333–42.

    Article  CAS  Google Scholar 

  6. Ross HJ, Law Y, Book WM, Broberg CS, Burchill L, Cecchin F, Chen JM, Delgado D, Dimopoulos K, Everitt MD, Gatzoulis M. Transplantation and mechanical circulatory support in congenital heart disease: a scientific statement from the American Heart Association. Circulation. 2016;133:802–20.

    Article  Google Scholar 

  7. Smythe JF, Dyck JD, Smallhorn JF, Freedom RM. Natural history of cardiac rhabdomyoma in infancy and childhood. Am J Cardiol. 1990;66:1247–9.

    Article  CAS  Google Scholar 

  8. Canter CE. Preoperative assessment and management of pediatric heart transplantation. Proc Pediatr Cardiol. 2000;11:91–7.

    Article  CAS  Google Scholar 

  9. O’Connor MJ, Lind C, Tang X, Gossett J, Weber J, Monos D, Shaddy RE. Persistence of anti-human leukocyte antibodies in congenital heart disease late after surgery using allografts and whole blood. J Heart Lung Transplant. 2013;32:390–7.

    Article  Google Scholar 

  10. Zeevi A, Lunz J, Feingold B, Shullo M, Bermudez C, Teuteberg J, Webber S. Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients. J Heart Lung Transplant. 2013;32:98–105.

    Article  Google Scholar 

  11. Dipchand AI, Rossano JW, Edwards LB, Kucheryavaya AY, Benden C, Goldfarb S, Levvey BJ, Lund LH, Meiser B, Yusen RD, Stehlik J. The Registry of the International Society for Heart and Lung Transplantation: Eighteenth Official Pediatric Heart Transplantation Report—2015; Focus theme: Early graft failure. J Heart Lung Transplant. 2015;34:1233–43.

    Article  Google Scholar 

  12. Kirklin JK, Young JB, McGiffin DC. Heart transplantation. London, England: Churchill Livingstone; 2002. ISBN: 0443076553.

    Google Scholar 

  13. Kirklin JK, Carlo WF, Pearce FB. Current expectations for cardiac transplantation in patients with congenital heart disease. World J Pediatr Congenit Heart Surg. 2016;7:685–95.

    Article  Google Scholar 

  14. Daly KP, Marshall AC, Vincent JA, et al. Endomyocardial biopsy and selective coronary angiography are low-risk procedures in pediatric heart transplant recipients: results of a multicenter experience. J Heart Lung Transplant. 2012;31:398–409.

    Article  Google Scholar 

  15. Shaddy RE, Bullock EA. Efficacy of 100 consecutive right ventricular endomyocardial biopsies in pediatric patients using the right internal jugular venous approach. Pediatr Cardiol. 1993;14:5–8.

    CAS  PubMed  Google Scholar 

  16. Goerler H, Simon A, Warnecke G, et al. Cardiac surgery late after heart transplantation: a safe and effective treatment option. J Thorac Cardiovasc Surg. 2010;140:433–9.

    Article  Google Scholar 

  17. Pearce FB, Carlo WF, Zaccagni HJ, Dabal RJ, Kirklin JK. Repair of early posttransplant endomyocardial biopsy-related tricuspid regurgitation in a child. World J Pediatr Congenit Heart Surg. 2015;6:295–7.

    Article  Google Scholar 

  18. Boucek MM, Mathis CM, Boucek RJ Jr, et al. Prospective evaluation of echocardiography for primary rejection surveillance after infant heart transplantation: comparison with endomyocardial biopsy. J Heart Lung Transplant. 1994;13(1 pt 1):66–73.

    CAS  PubMed  Google Scholar 

  19. Rosenthal DN, Chin C, Nishimura K, et al. Identifying cardiac transplant rejection in children: diagnostic utility of echocardiography, right heart catheterization and endomyocardial biopsy data. J Heart Lung Transplant. 2004;23:323–9.

    Article  Google Scholar 

  20. Loupy A, Duong Van Huyen JP, Hidalgo L, Reeve J, Racapé M, Aubert O, Venner JM, Falmuski K, Bories MC, Beuscart T, Guillemain R, François A, Pattier S, Toquet C, Gay A, Rouvier P, Varnous S, Leprince P, Empana JP, Lefaucheur C, Bruneval P, Jouven X, Halloran PF. Gene expression profiling for the identification and classification of antibody-mediated heart rejection. Circulation. 2017;135:917–35.

    Article  CAS  Google Scholar 

  21. Hervás I, Arnau MA, Almenar L, Pérez-Pastor JL, Chirivella M, Osca J, Bello P, Osa A, Martí JF, Vera F, Mateo A. Ventricular natriuretic peptide (BNP) in heart transplantation: BNP correlation with endomyocardial biopsy, laboratory and hemodynamic measures. Lab Investig. 2004;84:138–45.

    Article  Google Scholar 

  22. Kobashigawa J, Crespo-Leiro MG, Ensminger SM, Reichenspurner H, Angelini A, Berry G, Burke M, Czer L, Hiemann N, Kfoury AG, Mancini D. Report from a consensus conference on antibody-mediated rejection in heart transplantation. J Heart Lung Transplant. 2011;30:252–69.

    Article  Google Scholar 

  23. Wu GW, Kobashigawa JA, Fishbein MC, Patel JK, Kittleson MM, Reed EF, Kiyosaki KK, Ardehali A. Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes. J Heart Lung Transplant. 2009;28:417–22.

    Article  Google Scholar 

  24. Morrow WR, Frazier EA, Mahle WT, Harville TO, Pye SE, Knecht KR, Howard EL, Smith RN, Saylors RL, Garcia X, Jaquiss RD. Rapid reduction in donor-specific anti-human leukocyte antigen antibodies and reversal of antibody-mediated rejection with bortezomib in pediatric heart transplant patients. Transplantation. 2012;93:319.

    Article  CAS  Google Scholar 

  25. Kirklin JK, Brown RN, Huang ST, Naftel DC, Hubbard SM, Rayburn BK, McGiffin DC, Bourge RB, Benza RL, Tallaj JA, Pinderski LJ. Rejection with hemodynamic compromise: objective evidence for efficacy of photopheresis. J Heart Lung Transplant. 2006;25:283–8.

    Article  CAS  Google Scholar 

  26. Carlo WF, Pearce FB, George JF, Tallaj JA, McGiffin DC, Marques MB, Adamski J, Kirklin JK. Single-center experience with extracorporeal photopheresis in pediatric heart transplantation. J Heart Lung Transplant. 2014;33:624–8.

    Article  Google Scholar 

  27. Marques MB, Tuncer HH. Photopheresis in solid organ transplant rejection. J Clin Apher. 2006;21:72–7.

    Article  Google Scholar 

  28. Dichand AI. Current state of pediatric cardiac transplantation. Ann Cardiothorac Surg. 2018;7:31–55.

    Article  Google Scholar 

  29. Schowengerdt KO, Naftel DC, Seib PM, et al. Infection after pediatric heart transplantation: results of a multi-institutional study. J Heart Lung Transplant. 1997;16:1207–16.

    CAS  PubMed  Google Scholar 

  30. Gajarski RJ, Blume ED, Urschel S, Schechtman K, Zheng J, West LJ, Altamirano L, Miyamoto S, Naftel DC, Kirklin JK, Zamberlan MC, Canter CE. Infection and malignancy after pediatric heart transplantation: the role of induction therapy. J Heart Lung Transplant. 2011;30:299–308.

    Article  Google Scholar 

  31. Schowengerdt KO, Azeka E. Infection following pediatric heart transplantation. In: Pediatric heart transplantation. ISHLT Monograph, vol. 2. Philadelphia, PA: Elsevier; 2007.

    Google Scholar 

  32. Rostad CA, Wehrheim K, Kirklin JK, Naftel D, Pruitt E, Hoffman TM, L’Ecuyer T, Berkowitz K, Mahle WT, Scheel JN. Bacterial infections after pediatric heart transplantation: epidemiology, risk factors and outcomes. J Heart Lung Transplant. 2017;36:996–1003.

    Article  Google Scholar 

  33. Addonizio LJ, Boyle GJ. Posttransplant malignancy: risk factors, incidence, diagnosis, treatment, in pediatric heart transplantation. ISHLT Monograph, vol. 2. Philadelphia, PA: Elsevier; 2007.

    Google Scholar 

  34. Pahl E, Zales VR, Fricker FJ, Addonizio LJ. Posttransplant coronary artery disease in children. A multicenter national survey. Circulation. 1994;90(5 Pt 2):II56–60.

    CAS  PubMed  Google Scholar 

  35. Mulla NF, Johnston JK, VanderDussen L, Shirali GS, Larsen RL, Kuhn MA, Khan MA, Chinnock RE, Bailey LL. Early re-transplantation for post transplant coronary artery disease in children. J Heart Lung Transplant. 1997;16:71.

    Google Scholar 

  36. Kindel SJ, Law YM, Chin C, Burch M, Kirklin JK, Naftel DC, Pruitt E, Carboni MP, Arens A, Atz AM, Dreyer WJ. Improved detection of cardiac allograft vasculopathy: a multi-institutional analysis of functional parameters in pediatric heart transplant recipients. J Am Coll Cardiol. 2015;66:547–57.

    Article  Google Scholar 

  37. Rossano JW, Dipchand AI, Edwards LB, Goldfarb S, Kucheryavaya AY, Levvey BJ, Lund LH, Meiser B, Yusen RD, Stehlik J. The registry of the International Society for Heart and Lung Transplantation: Nineteenth Pediatric Heart Transplantation Report—2016; Focus theme: Primary diagnostic indications for transplant. J Heart Lung Transplant. 2016;35:1185–95.

    Article  Google Scholar 

  38. McGregor CGA, Byrne GW. Porcine to human heart transplantation: is clinical application now appropriate? J Immunol Res. 2017;2017:2534653.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiothoracic Surgery, Department of Surgery, Kirklin Institute for Research in Surgical Outcomes (KIRSO), University of Alabama at Birmingham (UAB), Birmingham, AL, USA

    James K. Kirklin

Authors
  1. James K. Kirklin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to James K. Kirklin .

Editor information

Editors and Affiliations

  1. Harefield Hospital, Royal Brompton & Harefield NHS Trust, London, UK

    Shahzad G. Raja

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kirklin, J.K. (2020). Pediatric Heart Transplantation. In: Raja, S. (eds) Cardiac Surgery. Springer, Cham. https://doi.org/10.1007/978-3-030-24174-2_110

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-24174-2_110

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-24173-5

  • Online ISBN: 978-3-030-24174-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation